Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brouquet A"'
Autor:
Antoine Brouquet, Bernard Nordlinger
Publikováno v:
Digestive Diseases. 30:132-136
Synchronous colorectal liver metastases include a wide variety of clinical presentation depending on the location and the extent of the primary tumor, the extent of metastatic disease in the liver, and the presence of extrahepatic disease. Only a min
Autor:
François Goldwasser, Olivier Soubrane, Stéphane Zalinski, Olivier Scatton, Antoine Brouquet, Catherine Brezault, Vincent Mallet, Benoit Terris
Publikováno v:
Annals of Surgery. 251:454-460
Background/Objective: Oxaliplatin-based chemotherapy induces sinusoidal obstruction syndrome (SOS) lesions in the nontumorous liver parenchyma, which may increase the risk of liver resection for colorectal liver metastases. The objective of this stud
Autor:
Alain Beauchet, Christophe Penna, Catherine Julié, Philippe Rougier, Stéphane Benoist, Antoine Brouquet, Bernard Nordlinger
Publikováno v:
Surgery. 145:362-371
Chemotherapy for colorectal liver metastases (CLM) may be associated with pathologic changes to the liver parenchyma, possibly increasing the risk of surgery. The aim of this study was to determine the risk factors for chemotherapy-associated liver i
Autor:
Julie Agostini, Franck Letourneur, Marie Seman, Sandrine Imbeaud, Pierre Laurent-Puig, Jessica Zucman-Rossi, Philippe Rougier, Stéphane Benoist, Antoine Brouquet, Nicolas Cagnard, Catherine Julié
Publikováno v:
Journal of hepatology. 56(4)
Background & Aims Oxaliplatin-based chemotherapy for colorectal liver metastases (CRLM) can result in vascular liver lesions such as sinusoidal dilatations. Physiopathology remains unclear and variability between patients suggests that there is indiv
Autor:
Antoine Brouquet, Bernard Nordlinger
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 10:266-267
Various factors are reported to affect the risk of local recurrence after resection of colorectal liver metastases. This article discusses the findings of a recent study that investigated the effect of fatty liver disease on the risk of recurrence.